SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form 10-Q - Quarterly report [Sections 13 or 15(d)]:
SEC Accession No. 0001347178-19-000017
Filing Date
2019-11-07
Accepted
2019-11-07 07:03:16
Documents
89
Period of Report
2019-09-30

Document Format Files

Seq Description Document Type Size
1 10-Q vnda930201910q.htm   iXBRL 10-Q 1530822
2 EXHIBIT 10.40 vndaex10400930201910q.htm EX-10.40 57633
3 EXHIBIT 10.41 vndaex10410930201910q.htm EX-10.41 56767
4 EXHIBIT 31.1 vndaex311930201910q.htm EX-31.1 13573
5 EXHIBIT 31.2 vndaex312930201910q.htm EX-31.2 13541
6 EXHIBIT 32.1 vndaex321930201910q.htm EX-32.1 9474
  Complete submission text file 0001347178-19-000017.txt   7386730

Data Files

Seq Description Document Type Size
7 XBRL TAXONOMY EXTENSION SCHEMA DOCUMENT vnda-20190930.xsd EX-101.SCH 55170
8 XBRL TAXONOMY EXTENSION CALCULATION LINKBASE DOCUMENT vnda-20190930_cal.xml EX-101.CAL 99381
9 XBRL TAXONOMY EXTENSION DEFINITION LINKBASE DOCUMENT vnda-20190930_def.xml EX-101.DEF 225968
10 XBRL TAXONOMY EXTENSION LABEL LINKBASE DOCUMENT vnda-20190930_lab.xml EX-101.LAB 668229
11 XBRL TAXONOMY EXTENSION PRESENTATION LINKBASE DOCUMENT vnda-20190930_pre.xml EX-101.PRE 409364
86 EXTRACTED XBRL INSTANCE DOCUMENT vnda930201910q_htm.xml XML 1221872
Mailing Address 2200 PENNSYLVANIA AVE NW SUITE 300E WASHINGTON DC 20037
Business Address 2200 PENNSYLVANIA AVE NW SUITE 300E WASHINGTON DC 20037 202-734-3400
Vanda Pharmaceuticals Inc. (Filer) CIK: 0001347178 (see all company filings)

IRS No.: 030491827 | State of Incorp.: DE | Fiscal Year End: 1231
Type: 10-Q | Act: 34 | File No.: 001-34186 | Film No.: 191198087
SIC: 2834 Pharmaceutical Preparations